Lysodren (mitotane)

Approved for LYSODREN is indicated for the treatment of patients with inoperable, functional or nonfunctional, adrenocortical carcinoma (ACC).. Mitotane is an adrenal cytotoxic agent with an unknown mechanism of action. Mitotane modifies the peripheral metabolism of steroids and directly suppresses the adrenal cortex. A reduction in… Side effects, costs, interactions, manufacturer, and generic…

Loading full data from Know Your Drugs Institute…